AbbVie
ABBV
#28
Rank
HK$3.575 T
Marketcap
HK$2,023
Share price
-1.81%
Change (1 day)
24.78%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2026 (TTM): HK$16.06

According to AbbVie's latest financial reports the company's current EPS (TTM) is HK$16.12. In 2025 the company made an earnings per share (EPS) of HK$18.75 a decrease over its 2024 EPS that were of HK$18.98.

EPS history for AbbVie from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$16.06-14.31%
2025HK$18.75-1.26%
2024HK$18.98-11.86%
2023HK$21.54-58.95%
2022HK$52.482.49%
2021HK$51.20121.58%
2020HK$23.11-44.7%
2019HK$41.7845.84%
2018HK$28.659.72%
2017HK$26.11-9.54%
2016HK$28.8716.28%
2015HK$24.82184.1%
2014HK$8.74-57.15%
2013HK$20.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.27-36.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.24 1,272.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.50 603.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$73.29 354.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$58.16 260.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.90 73.08%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$54.48 237.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$30.46 88.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$52.60 226.23%๐Ÿ‡บ๐Ÿ‡ธ USA